Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 51
Filtrar
1.
Rev. chil. infectol ; 38(1): 15-21, feb. 2021. tab
Artigo em Espanhol | LILACS | ID: biblio-1388199

RESUMO

INTRODUCCIÓN: Taurolidina es una molécula con propiedades anti-endotóxicas, antimicrobianas y anti-inflamatorias, que inhibe la adhesión bacteriana, lo que ha permitido usarla como terapia de sellado en catéter venoso central de larga duración (CVC) para prevenir infecciones del torrente sanguíneo asociadas a CVC (ITS-CVC). OBJETIVO: Dar a conocer una experiencia preliminar, la primera en Chile, con taurolidina como terapia de sellado para prevenir ITS-CVC y reportar su eficacia. MÉTODO: Se instiló una solución en base a taurolidina en el CVC de tres niños con insuficiencia intestinal, dependientes de alimentación parenteral, atendidos en un hospital terciario de la Región de Valparaíso, y se comparó la tasa de ITS-CVC antes y después de su uso mediante un análisis retrospectivo. RESULTADOS: en los dos pacientes que iniciaron terapia de sellado inmediatamente después de instalado el CVC, la tasa de ITS-CVC se logró llevar a cero, mientras que, en el tercero, portador de un CVC instalado 9 meses antes, con ITS-CVC recurrentes, un nuevo episodio de ITS-CVC obligó a suspender la profilaxis. CONCLUSIONES: La terapia de sellado con solución en base a taurolidina previno las ITS-CVC cuando ésta se inició al momento de instalarse el CVC, no así en un CVC antiguo con ITS-CVC recurrentes.


BACKGROUND: Taurolidine is a molecule with anti-endotoxic, anti-microbial and anti-inflammatory properties that inhibits bacterial adhesion, allowing for its use as lock therapy for the prevention of catheter-related bloodstream infections (CRBSI) in long-term central venous catheters (CVC). AIM: To report a preliminary experience, the first one in Chile, using lock therapy with taurolidine for the prevention of CRBSI and to report its efficacy. METHOD: A taurolidine-based solution was instilled in the CVC of three children with intestinal insufficiency dependent on parenteral nutrition, attended in a Chilean tertiary hospital, and the rate of CRBSI before and after its use was compared in retrospect. RESULTS: In the two patients who started lock therapy immediately after the installation of their CVC, the rate of CRBSI was brought to zero, whereas in the third patient, who had a 9 months-old CVC with a recurrent CRBSI history, an intercurrent CRBSI forced discontinuation of the prophylaxis. CONCLUSIONS: Lock therapy with a taurolidine-based solution prevented CRBSIs when it was begun immediately after installing the CVC, in contrast with an old CVC with a history of recurrent CRBSIs.


Assuntos
Humanos , Lactente , Criança , Tiadiazinas , Cateterismo Venoso Central , Bacteriemia , Infecções Relacionadas a Cateter , Taurina/análogos & derivados , Tiadiazinas/uso terapêutico , Cateterismo Venoso Central/efeitos adversos , Chile , Infecções Relacionadas a Cateter/prevenção & controle , Centros de Atenção Terciária
2.
Electron. j. biotechnol ; 45: 46-52, May 15, 2020. tab, graf, ilus
Artigo em Inglês | LILACS | ID: biblio-1177424

RESUMO

BACKGROUND: The present study analyzed the synergistic protective effect of ß-alanine and taurine against myocardial ischemia/reperfusion. Myocardial infarct size, lipid peroxidation, and levels of glutathione peroxidase (Gpx), superoxide dismutase (SOD), reduced glutathione (GSH), catalase, tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), reactive oxygen species (ROS), apoptosis, and the mRNA and protein expression of Janus kinase 2 (JAK2) and signal transducer and activator 3 of transcription (STAT3) were determined. The molecular docking was carried out by using AutoDock 4.2.1. RESULTS: Combined treatment with ß-alanine and taurine reduced myocardial infarct size, lipid peroxidation, inflammatory marker, ROS levels, and apoptosis and increased Gpx, SOD activity, GSH, and catalase activity. Furthermore, combined treatment significantly reduced JAK2 and STAT3 mRNA and protein expression compared with the control. The small molecule was docked over the SH2 domain of a STAT3, and binding mode was determined to investigate the inhibitory potential of ß-alanine and taurine. ß-Alanine bound to SH2 domain with ΔG of -7.34 kcal/mol and KI of 1.91 µM. Taurine bound to SH2 domain with ΔG of -7.38 kcal/mol and KI of 1.95 µM. CONCLUSION: Taken together, these results suggest that the combined supplementation of ß-alanine and taurine should be further investigated as an effective therapeutic approach in achieving cardioprotection in myocardial ischemia/reperfusion.


Assuntos
Animais , Masculino , Ratos , Taurina/uso terapêutico , Cardiotônicos/uso terapêutico , Traumatismo por Reperfusão/tratamento farmacológico , beta-Alanina/uso terapêutico , Isquemia Miocárdica/tratamento farmacológico , Superóxido Dismutase , Imuno-Histoquímica , Peroxidação de Lipídeos , Espécies Reativas de Oxigênio , Ratos Wistar , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Modelos Animais de Doenças , Janus Quinase 2 , Simulação de Acoplamento Molecular , Glutationa Peroxidase , Cardiopatias/tratamento farmacológico , Inflamação
3.
Biol. Res ; 53: 53-53, 2020. ilus, tab
Artigo em Inglês | LILACS | ID: biblio-1505779

RESUMO

OBJECTIVES: Our previous study indicated that aerobic exercise relieves cognitive impairment in patients with vascular cognitive impairment (VCI) via regulating brain-derived neurotrophic factor (BDNF), but the mechanism is not yet clear. This study aimed to explore whether lncRNA taurine upregulated gene 1 (TUG1) participates in the process of VCI by regulating BDNF. METHODS: The expressions of TUG1 and BDNF in the serum of VCI patients were detected. The potential molecular mechanisms of TUG1 in regulating hippocampal neuronal apoptosis were explored in oxygen and glucose deprivation-induced (OGD-induced) hippocampal cell line HT22. The VCI mouse model was established, and TUG1 and BDNF were overexpressed via lentivirus injection. The cognitive impairment of mice was detected by the Morris water maze experiment after the aerobic exercise. RESULTS: The level of TUG1 was elevated in the serum of VCI patients compared with the control group. The knockdown of TUG1 in OGD-induced HT22 cells increased BDNF level and decreased cell apoptosis, and the downregulation of BDNF restored the decreased cell apoptosis. RNA immunoprecipitation and RNA pull-down assays showed that TUG1 could bind to BDNF protein. The aerobic exercise alleviated cognitive impairment and inhibited hippocampal apoptosis in VCI mice. Meanwhile, the overexpression of TUG1 reversed the therapeutic effects of aerobic exercise on cognitive impairment. CONCLUSIONS: The knockdown of TUG1 reduced hippocampal neuronal apoptosis and participates in the aerobic exercise-alleviated VCI, which was partly through regulating BDNF.


Assuntos
Humanos , Animais , Masculino , Camundongos , Condicionamento Físico Animal , Apoptose , Disfunção Cognitiva/genética , Disfunção Cognitiva/terapia , RNA Longo não Codificante/genética , Neurônios/patologia , Taurina , Linhagem Celular , Camundongos Knockout , Fator Neurotrófico Derivado do Encéfalo , Proliferação de Células , Técnicas de Silenciamento de Genes , RNA Longo não Codificante/sangue , Hipocampo/citologia , Camundongos Endogâmicos C57BL
4.
Braz. j. med. biol. res ; 53(11): e9798, 2020. graf
Artigo em Inglês | LILACS, Coleciona SUS | ID: biblio-1132489

RESUMO

Osteoblast differentiation is an effective way to promote bone formation. Long non-coding RNA taurine upregulated 1 (TUG1) has been identified as a crucial modulator of multiple biological processes. This study was designed to investigate the function of TUG1 in the proliferation and differentiation of osteoblast precursor cells hFOB1.19. In this study, we found that TUG1 promoted hFOB1.19 cell proliferation, while TUG1 knockdown hindered cell proliferation. TUG1 and cannabinoid receptor 2 (CNR2) were upregulated, while miR-545-3p was down-regulated in hFOB1.19 cells undergoing osteoblastic differentiation. TUG1 induced osteoblast differentiation by increasing alkaline phosphatase (ALP) activity and the expression of osteoblastic differentiation markers. TUG1 was a sponge of miR-545-3p and regulated osteoblastic differentiation by modulating miR-545-3p. Moreover, miR-545-3p directly targeted CNR2 and restored the effect of CNR2 on osteoblastic differentiation. In conclusion, TUG1 accelerated the proliferation and differentiation of osteoblasts by sponging miR-545-3p and increasing CNR2 expression, which might provide a new biomarker for bone diseases.


Assuntos
Humanos , RNA Longo não Codificante/genética , Osteoblastos , Taurina , Diferenciação Celular , MicroRNAs , Receptor CB2 de Canabinoide , Proliferação de Células
5.
Rev. chil. infectol ; 36(4): 414-420, ago. 2019. tab, graf
Artigo em Espanhol | LILACS | ID: biblio-1042656

RESUMO

Resumen Taurolidina es un antiséptico de amplio espectro usado como solución de terapia de sellado (lock therapy) en adultos y niños portadores de catéter venoso central de larga duración (CVC) para prevenir las infecciones asociadas a CVC (IACVC). No induce desarrollo de resistencia y tiene efectos adversos leves y fugaces, lo que lo convierte en una alternativa, tanto como terapia de sellado como para la profilaxis de las IACVC, en este grupo de pacientes.


Taurolidine is a broad-spectrum antiseptic used as lock therapy solution in adult and pediatric patients with long term central venous catheters (CVC) for the prevention of catheter related bloodstream infections (CRBSI). Taurolidine doesn't induce the resistant development and has only minor and brief side effects, which makes it an alternative both as a lock therapy and for the prevention of CRBSI in this group of patients.


Assuntos
Humanos , Taurina/análogos & derivados , Tiadiazinas/administração & dosagem , Infecções Relacionadas a Cateter/prevenção & controle , Cateteres Venosos Centrais/efeitos adversos , Anti-Infecciosos Locais/administração & dosagem , Taurina/administração & dosagem
6.
J. Phys. Educ. (Maringá) ; 30: e3033, 2019. tab, graf
Artigo em Português | LILACS | ID: biblio-1012500

RESUMO

RESUMO O objetivo do estudo foi verificar se bebidas enegéticas com diferentes composições nutricionais afetam o balanço hidro-eletrolítico de corredores de resistência. Doze homens participaram desse estudo duplo cego e crossover randomizado, ingerindo 3mg.kg-1 de cafeína de bebida energética convencional e sugar free, e um placebo carboidratado e não cafeinado, 40 minutos antes de sessão de exercício em ambiente termoneutro. Em cada situação experimental, os avaliados realizaram exercício de corrida em esteira com duração de 60 minutos e intensidade constante entre 65 e 75% do VO2max, seguidos por um sprint correspondendo a 100% do VO2max até a exaustão. Foram avaliados o peso corporal (PC), desidratação absoluta e relativa, densidade da urina, taxa de sudorese e níveis de Na+, K+ e hematócrito. Durante o exercício os avaliados receberam somente água a cada 15 minutos. Foi verificada alteração nos níveis de densidade da urina antes e depois do exercício para todos os tratamentos (p<0,05). Não houve diferença significativa entre as bebidas nos níveis de Na+, K+ e hematócrito (p>0,05) mantendo-se dentro dos níveis de normalidade. Conclui-se que diferentes tipos de bebidas energéticas não afetam o balanço hidro-eletrolítico de corredores de resistência ao longo do exercício.


ABSTRACT This work compares the effects promoted by energy drinks with diferente nutricional compositions on the hydro-electrolytic balance of resistance runners. Twelve men participated in this double blinded, randomized crossover study, ingesting 3mg*Kg-1 of a conventional energy drink with caffeine or sugar-free, and a placebo 40-minutes before tests on thermoneutral environment. The duration of the session was 60 minutes with constant intensity between 65 and 75% of VO2max, followed by a sprint corresponding to 100% of VO2max until exhaustion. There were evaluated body weight (BW), absolute and relative dehydration, urine density, sweating rate and Na+, K+ and hematocrit levels. During the exercise, the participants drunk only water every 15 minutes. Changes in urine density levels were observed before and after exercise for all procedures (p <0.05). There was no significant difference on the levels of Na+, K+ and hematocrit between the drinks (p> 0.05), remaining within normal levels. It is concluded that different types of energy drinks do not affect the hydro-electrolytic balance of resistance runners during the exercise.


Assuntos
Humanos , Masculino , Adulto Jovem , Bebidas Energéticas , Teste de Caminhada , Taurina , Cafeína , Diurese
7.
Arq. bras. med. vet. zootec. (Online) ; 70(6): 1862-1866, nov.-dez. 2018. ilus
Artigo em Português | LILACS, VETINDEX | ID: biblio-970589

RESUMO

A cardiomiopatia dilatada é uma doença de caráter crônico, que compromete a função cardíaca, resultando em desequilíbrio da circulação sanguínea e da homeostase corporal do animal. Este relato apresenta a evolução do quadro clínico e o tratamento de cardiomiopatia dilatada em um exemplar cativo de tamanduá-bandeira. O animal apresentou quadro clínico de insuficiência cardíaca e foi submetido a duas baterias de exames laboratoriais e de imagem em um período de três meses. Posteriormente, foi iniciado o tratamento com pimobendan e suplementação de taurina, resultando em resposta positiva e melhora dos sinais clínicos do paciente. Os achados ecocardiográficos do caso foram compatíveis com cardiomiopatia dilatada com sinais evidentes de diminuição progressiva das frações de ejeção, bem como encurtamento e aumento expressivo das câmaras cardíacas, quando se comparou este caso ao de cães de grande porte e animais saudáveis da mesma espécie. O tratamento com inotrópico positivo, suplementação dietética de taurina e diuréticos se mostrou eficiente em controlar os sinais clínicos do animal.(AU)


The dilated cardiomyopathy it is a chronic disease that leads to a cardiac dysfunction, resulting in unstable blood circulation and specimen body homeostasis. This description shows the dilated cardiomyopathy evolution and treatment in a giant anteater captive model. The patient presented cardiac insufficient clinical condition and was submitted to two sets of laboratorial and image exams in three months. Furthermore, the treatment started with pimobendam and taurine supplementation, leading to satisfactory response to treatment and clinical improvement. The echocardiographic findings were compatible with dilated cardiomyopathy, moreover clear evidence of progressive reduction at the ejection portions and shortening and expressive increase of the cardiac chamber when compared to large dogs and healthy animals of the same species. Treatment with positive inotropic and taurine dietary supplement revealed as effective in clinical managementr.(AU)


Assuntos
Animais , Ecocardiografia/estatística & dados numéricos , Cardiomiopatia Dilatada/diagnóstico , Xenarthra/anormalidades , Taurina
8.
Motriz (Online) ; 24(1): e1018137, 2018. graf
Artigo em Inglês | LILACS | ID: biblio-895055

RESUMO

AIM: Taurine is considered a semi-essential amino acid characterized by having various physiological functions in the body that modulate mechanisms of action involved in the muscle contraction process, increased energy expenditure, insulin signaling pathway, carbohydrate metabolism, and scavenging free radicals. These functions are crucial for aerobic exercise performance; thus, taurine supplementation may benefit athletes' performance. The objective of this study was to evaluate the effects of taurine supplementation on the resting energy expenditure and physical performance of swimming athletes. METHODS: In a double-blind study, 14 male swimmers were randomized into two groups: the taurine group (n = 7) and the placebo group (n = 7), which received 3 g per day of taurine or placebo in capsules during 8 weeks. Resting energy expenditure, plasma taurine, physical performance, anthropometry, dietary consumption were measured and an incremental test was performed to determine their maximal front crawl swimming performances before and after the 8-week period. RESULTS: The levels of serum taurine (p < 0.0001) and lactate (p = 0.0130) showed a significant increase in the taurine group; however, the other variables were not different. No changes were observed in the resting energy expenditure, mean speed performed, and the anaerobic threshold of the swimmers post-supplementation period. CONCLUSION: Supplementation of taurine increased plasma concentrations of this amino acid, but did not lead to significant changes in food intake, rest energy expenditure, and athletes' performance. However, the supplemented group presented a higher lactate production, suggesting a possible positive effect of taurine on the anaerobic lactic metabolism.(AU)


Assuntos
Humanos , Masculino , Desempenho Atlético , Metabolismo Energético/fisiologia , Fenômenos Fisiológicos da Nutrição do Lactente , Natação/fisiologia , Taurina
9.
Arq. bras. med. vet. zootec ; 69(1): 198-204, jan.-fev. 2017. tab
Artigo em Português | LILACS, VETINDEX | ID: biblio-836694

RESUMO

O objetivo deste estudo foi avaliar o efeito do fornecimento de dietas pós-eclosão suplementadas com diferentes fontes de gordura insaturada e adicionadas ou não de taurina e glicina sobre o desempenho produtivo, a biometria e a morfometria do intestino delgado de pintos de corte de um a 21 dias de idade. Foram utilizados 480 pintos de corte machos de um dia de idade da linhagem Cobb. O delineamento foi inteiramente ao acaso, em esquema fatorial 2 x 4, com e sem suplementação de taurina e glicina e quatro dietas (controle, óleo de peixe, de soja e de girassol), totalizando oito tratamentos com seis repetições de 10 aves cada. As rações experimentais foram fornecidas de zero a quatro dias de idade. O desempenho zootécnico foi avaliado ao alojamento e aos quatro, sete e 21 dias de idade. Nestas mesmas datas, foram sacrificadas duas aves por unidade experimental para biometria do intestino e histomorfometria da mucosa do intestino. A adição de diferentes fontes de gordura e a suplementação de glicina e taurina às dietas de transição não influenciaram o desempenho produtivo de um a 21 dias. A suplementação das dietas com glicina e taurina alterou a morfologia da mucosa intestinal, principalmente do duodeno, resultando em maior comprimento do vilo e relação vilo:cripta. Entretanto, parte dos efeitos positivos depende do tipo de óleo adicionado, mostrando que dietas pós-eclosão acrescidas de fontes de lipídios podem ser benéficas no desenvolvimento da capacidade funcional do intestino de frangos de corte.(AU)


The aim of this study was to assess post-hatch diets supplemented with different sources of unsaturated fat and added or not with taurine and glycine on the productive performance, biometry and morphology of small intestine of chicks from 1 to 21 days of age. Four hundred and eighty (480) one day old male broiler Cobb chicks were used. The experimental design was completely randomized in a factorial 2 x 4, with and without supplemental taurine and glycine and 4 diets (control, fish, soy and sunflower oil), totaling six treatments with six repetitions of 10 birds each. The experimental diets were supplied from 0 to 4 days old. The performance was evaluated in housing and 4, 7 and 21 days of age. On these same dates, 2 birds per experimental unit were sacrificed for gut biometrics and histomorphometry of intestinal mucosa. The addition of different sources of fat, glycine and taurine supplementation on transition diets did not influence productive performance from 1 to 21 days. Supplementation of diets with glycine and taurine altered the morphology of the intestinal mucosa, mainly of the duodenum, resulting in greater length of villi and villi: crypt ratio. However, the positive effects depend on the type of oil added, showing that post-hatch diets increased with lipid sources may be beneficial in the development of the functional capacity of the intestine of broilers.(AU)


Assuntos
Animais , Galinhas/crescimento & desenvolvimento , Dieta/veterinária , Glicina , Taurina , Aumento de Peso , Ácidos e Sais Biliares , Gorduras Insaturadas na Dieta , Mucosa Intestinal , Lipídeos
10.
Braz. j. med. biol. res ; 47(12): 1068-1074, 12/2014. graf
Artigo em Inglês | LILACS | ID: lil-727656

RESUMO

Taurine (2-aminoethanesulfonic acid) is widely distributed in animal tissues and has diverse pharmacological effects. However, the role of taurine in modulating smooth muscle contractility is still controversial. We propose that taurine (5-80 mM) can exert bidirectional modulation on the contractility of isolated rat jejunal segments. Different low and high contractile states were induced in isolated jejunal segments of rats to observe the effects of taurine and the associated mechanisms. Taurine induced stimulatory effects on the contractility of isolated rat jejunal segments at 3 different low contractile states, and inhibitory effects at 3 different high contractile states. Bidirectional modulation was not observed in the presence of verapamil or tetrodotoxin, suggesting that taurine-induced bidirectional modulation is Ca2+ dependent and requires the presence of the enteric nervous system. The stimulatory effects of taurine on the contractility of isolated jejunal segments was blocked by atropine but not by diphenhydramine or by cimetidine, suggesting that muscarinic-linked activation was involved in the stimulatory effects when isolated jejunal segments were in a low contractile state. The inhibitory effects of taurine on the contractility of isolated jejunal segments were blocked by propranolol and L-NG-nitroarginine but not by phentolamine, suggesting that adrenergic β receptors and a nitric oxide relaxing mechanism were involved when isolated jejunal segments were in high contractile states. No bidirectional effects of taurine on myosin phosphorylation were observed. The contractile states of jejunal segments determine taurine-induced stimulatory or inhibitory effects, which are associated with muscarinic receptors and adrenergic β receptors, and a nitric oxide associated relaxing mechanism.


Assuntos
Animais , Masculino , Jejuno/efeitos dos fármacos , Contração Muscular/efeitos dos fármacos , Músculo Liso/efeitos dos fármacos , Miosinas/metabolismo , Taurina/farmacologia , Antagonistas Adrenérgicos alfa/farmacologia , Antagonistas Adrenérgicos beta/farmacologia , Atropina/farmacologia , Bloqueadores dos Canais de Cálcio/farmacologia , Cimetidina/farmacologia , Difenidramina/farmacologia , Sistema Nervoso Entérico/efeitos dos fármacos , Antagonistas dos Receptores Histamínicos H1/farmacologia , /farmacologia , Jejuno/fisiologia , Antagonistas Muscarínicos/farmacologia , Quinase de Cadeia Leve de Miosina/metabolismo , Óxido Nítrico Sintase/antagonistas & inibidores , Óxido Nítrico/metabolismo , Fosforilação , Fentolamina/farmacologia , Propranolol/farmacologia , Ratos Sprague-Dawley , Taurina/antagonistas & inibidores , Tetrodotoxina/farmacologia , Verapamil/farmacologia
11.
Int. j. morphol ; 31(3): 1081-1089, set. 2013. ilus
Artigo em Inglês | LILACS | ID: lil-695004

RESUMO

Carbamazepine is widely used in a broad spectrum of psychiatric and neurological disorders. Idiosyncratic hepatotoxicity is a well-known adverse reaction associated with carbamazepine. Hepatotoxicity is rare, but a real concern when initiating therapy. It was found that oxidative stress is a potential mechanism for carbamazepine-induced hepatotoxicity. Present study evaluated the hepato protective role of taurine and melatonin against carbamazepine-induced hepatotoxicity. Hepatocytes were prepared by the method of collagenase enzyme perfusion via portal vein. Cells were treated with 400 uM carbamazepine, 1mM taurine, and 1mM melatonin. Cell death, reactive oxygen species formation, lipid peroxidation, and mitochondrial membrane depolarization were assessed as toxicity markers and the effects of taurine and melatonin administration on them were investigated. Our results showed that carbamazepine induced oxidative stress; increased ROS formation and lipid peroxidation products and also decreased mitochondrial membrane potential (DYm). Carbamazepine caused a decrease in cellular glutathione content and an elevation in oxidized glutathione levels. Our investigation showed that preincubation of hepatocytes with taurine (1 mM) could alleviate oxidative damages induced by carbamazepine; melatonin was also a good antioxidant to protect hepatocytes against cytotoxicity induced by carbamazepine. It may be concluded that taurine and melatonin are effective antioxidants to prevent carbamazepine-induced hepatotoxicity. Following our findings, further studies are suggested on the antioxidant effects of taurine and melatonin in patients receiving carbamazepine.


La carbamazepina es ampliamente utilizada en un gran espectro de trastornos psiquiátricos y neurológicos. La hepatotoxicidad idiosincrásica es una conocida reacción adversa asociada con la carbamazepina. La hepatotoxicidad es rara, pero es una preocupación real al iniciar el tratamiento. Se ha reportado que el estrés oxidativo es un potencial mecanismo para la hepatotoxicidad inducida por carbamazepina. El presente estudio evaluó la función hepato-protectora de la taurina y melatonina contra la hepatotoxicidad inducida por carbamazepina. Los hepatocitos se prepararon por el método de perfusión de la enzima colagenasa a través de la vena porta. Las células fueron tratadas con 400 uM de carbamazepina, 1 mM de taurina, y 1 mM de melatonina. La muerte celular, formación de especies reactivas de oxígeno (ERO), peroxidación de lípidos, y despolarización de la membrana mitocondrial fueron evaluadas como marcadores de toxicidad, junto con investigar los efectos de la taurina y melatonina administrada en ellos. Nuestros resultados mostraron estrés oxidativo inducido por carbamazepina, con aumento de las ERO, formación de productos de la peroxidación lipídica y disminución del potencial de membrana mitocondrial (DYm). La carbamazepina causó una disminución en el contenido celular de glutatión y una elevación de los niveles de glutatión no-oxidado. Se observó que la preincubación de los hepatocitos con taurina (1 mM) podría aliviar los daños oxidativos inducidos por carbamazepina; además la melatonina también fue un buen antioxidante para proteger a los hepatocitos. Se puede concluir que tanto la taurina y melatonina son antioxidantes eficaces para prevenir la hepatotoxicidad inducida por carbamazepina. Tras nuestros resultados, se sugiere estudiar los efectos antioxidantes de la taurina y melatonina en pacientes tratados con carbamazepina.


Assuntos
Masculino , Animais , Ratos , Carbamazepina/efeitos adversos , Hepatócitos , Melatonina/administração & dosagem , Taurina/administração & dosagem , Doença Hepática Induzida por Substâncias e Drogas , Estresse Oxidativo , Ratos Sprague-Dawley
12.
Rev. bras. hematol. hemoter ; 35(1): 44-51, 2013. tab
Artigo em Inglês | LILACS | ID: lil-670459

RESUMO

BACKGROUND: The complete blood count is one of the most common routine tests. This study aimed to evaluate possible effects of the antioxidant taurine on the complete blood count of whole blood stored at room temperature and at 4ºC over seven days. METHODS: Venous blood samples of 25 healthy males were distributed into two sets of tubes with each set of four tubes containing 50 µL of solutions with zero, 2.5 g/L, 5 g/L, 10 g/L taurine. The tubes were kept at room temperature or at 4ºC. Complete blood counts were performed on seven successive days. The mean percentage changes [Δ = (mean value - mean baseline value) / mean baseline value x 100] were calculated and compared. RESULTS: Complete blood count parameters exhibited different patterns of behavior which were affected by the storage temperature, time and taurine concentration. Taurine at room temperature significantly enhancedthe stability of: the platelet count over seven days (Δ7 at 2.5, 5 and 10 g/L taurine were 5.45, 6.11, and 5.80 x 10(9) cells/L, respectively); the red blood cell count over five days (Δ5 at 2.5, 5 and 10 g/L taurine were 1.59, 2.79, and 1.98 x 10(12) cells/L, respectively); mean corpuscular hemoglobin over five days (Δ5 at 2.5, 5 and 10 g/L taurine were -0.91,-1.52 and -0.84 fl respectively); and red cell distribution width over two days (Δ2 at 2.5, 5 and 10 g/L taurine were 0.90%, 1.30% and -0.1%, respectively). No additional stabilizing effects of taurine were reported for the mean corpuscular volume, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, hematocrit and hemoglobin, while it negatively affected the white blood cell stability. CONCLUSION: Complete blood count parameters exhibited variable stability patterns in respect to temperature, time and taurine concentration.


Assuntos
Humanos , Masculino , Adolescente , Adulto , Contagem de Plaquetas , Taurina , Preservação de Sangue , Temperatura Baixa , Antioxidantes
14.
Acta sci., Health sci ; 34(ed. esp): 263-269, jan.-dez. 2012. tab, ilus
Artigo em Inglês | LILACS | ID: biblio-1476

RESUMO

Studies show that physical exercise (PE) is associated with a reduced fat accumulation and increased insulin sensitivity, and taurine (TAU) improves glucose homeostasis in lean rodents. The aim in this work was evaluate the effects of supplementing TAU and practice of PE, associated or not, on obesity and glucose homeostasis on obese MSG-mice. Neonate male Swiss mice received injections of monosodium glutamate (MSG group) or saline (CON group). From the 30th to the 90th day of life, one group of animals received TAU in drinking water (MSG TAU group), another was subjected to PE (MSG PE group) and a third group underwent both procedures (MSG PE TAU group). Mice treated with MSG become obese, hypertriglyceridemic, glucose intolerant and insulin resistant. The supplementation with TAU and the PE, isolated or associated, reduced the triglycerides (38%), glucose intolerance (around 30%) and KITT (79%) in MSG-obese animals, but did not influence the accumulation of fat. Interestingly, the combination of both strategies significantly reduced the insulin resistance, compared to animals subjected to isolated strategies. In conclusion, the supplementation with TAU and PE, isolated or associated, did not influence the accumulation of fat in MSG-obese mice, however, reduce the triglycerides and insulin resistance.


O exercício físico (EF) está associado à redução do acúmulo de gordura e aumento na sensibilidade à insulina e a taurina (TAU) melhora a homeostase glicêmica em roedores magros. Objetivou-se avaliar os efeitos da suplementação com TAU e do EF, associados ou não, sobre a obesidade e a homeostase glicêmica em camundongos obesos-MSG. Camundongos Swiss machos neonatos receberam injeções de glutamato monossódico (grupo MSG) ou salina (grupo CON). Do 30º ao 90º dia de vida, um grupo de animais MSG recebeu TAU na água de beber (MSG TAU); outro foi submetido ao EF (MSG EX) e um terceiro grupo foi submetido aos dois procedimentos (MSG EX TAU). Camundongos -MSG tornaram-se obesos, hipertrigliceridêmicos, intolerantes à glicose e resistentes à insulina. A suplementação com TAU e o EF, associados ou isolados, reduziram a trigliceridemia (38%), a intolerância à glicose (30%) e o KITT (79%) nos animais obesos-MSG, porém, não influenciaram o acúmulo de gordura. A associação das duas estratégias diminui significativamente a resistência à insulina, comparado aos animais submetidos às estratégias isoladas. Conclui-se que a suplementação com TAU e o EF, associados ou isolados, não influenciam no acúmulo de gordura dos camundongos obesos-MSG, porém, diminuem a trigliceridemia e a resistência à insulina.


Assuntos
Camundongos , Natação , Taurina , Glicemia , Resistência à Insulina , Exercício Físico , Obesidade
15.
Botucatu; s.n; 2012. 79 p. ilus, tab.
Tese em Português | LILACS | ID: lil-750907

RESUMO

O objetivo do nosso estudo foi de avaliar a influência da administração de taurina sobre a remodelação após o infarto em ratos, por meio de análise de sobrevida e de variáveis morfológicas, funcionais, bioquímicas, celulares e intersticiais cardíacas. Foram utilizados ratos wistar, machos, entre 200 – 250g foram submetidos ao infarto experimental. Após 48hs do procedimento, os animais sobreviventes foram alocados em dois grupos aleatoriamente: grupo IAM (n=31), o qual recebeu água potável e grupo IAM-T (n=30), que recebeu 3% de taurina diluída na água. O grupo controle (n=10) foi composto por animais não infartados e recebeu água potável. Após 3 meses de acompanhamento foi realizado estudo morfológico e funcional pelos seguintes métodos: coração isolado, ecocardiograma, morfometria e histologia. O estudo bioquímico foi realizado por HPLC (para determinar as concentrações e taurina no plasma e no tecido cardíaco). A imunohistoquímica foi utilizada para avaliar a conexina 43 e apoptose. Por meio da zimografia avaliou-se as metaloproteases, por espectrofotometria foram avaliados estresse oxidativo e metabolismo energético e por western blot avaliou-se a resposta antioxidante. A análise estatística foi realizada pelo teste de ANOVA de uma via, t de Student, curva de Kaplan Méier e long – rank. O nível de significância adotado foi de 5%. A concentração de taurina plasmática (C = 49 (38 – 54,2) (μmol/L); IAM = 74,6 (58,7 – 83) (μmol/L); IAM-T = 363 (157 - 477,4) (μmol/L); p = 0,004) e no tecido cardíaco (C = 0,100 ± 0,04 (μmol/g); IAM = 0,175 ± 0,07 (μmol/g); IAM-T = 0,419± 0,187 (μmol/g); p = 0,022) foi maior no grupo IAM-T quando comparado com controle e IAM...


The aim of our study was to evaluate the influence of taurine administration on cardiac remodeling after myocardial infarction in rats by survival analysis and morphological, functional, biochemical, cellular and interstitial evalluation. Methods: Wistar male rats, weighting 200 - 250g were subjected to experimental myocardial infarction. 48 hours after the procedure, the surviving animals were randomly allocated into two groups: IAM group (n = 31), who received drinking tap water and T-IAM group (n = 30), who received 3% of taurine diluted in tap water. The control group (n = 10) was composed of non infarcted animals, who received drinking tap water. After 3 months of follow-up, morphological and functional study was conducted by the following. Isolated heart, echocardiography, histology and morphometry. Biochemical analysis was performed by HPLC (to determine the concentrations of taurine in plasma and heart tissue). Immunohistochemistry was used to evaluate connexin 43 and apoptosis. Metalloproteases was evaluated by zymography, oxidative stress and energy metabolism were evaluated by spectrophotometry and the antioxidant response, by western blot. Statistical analysis was performed by oneway ANOVA, Student t test, Kaplan Meier and long – rank tests. The level of significance was set at 5%...


Assuntos
Animais , Masculino , Ratos , Apoptose , Metabolismo Energético , Infarto do Miocárdio/induzido quimicamente , Estresse Oxidativo , Remodelação Ventricular , Taurina/fisiologia , Ratos Wistar
16.
Braz. j. med. biol. res ; 44(7): 618-623, July 2011. ilus
Artigo em Inglês | LILACS | ID: lil-595709

RESUMO

Taurine has positive effects on bone metabolism. However, the effects of taurine on osteoblast apoptosis in vitro have not been reported. The aim of this study was to investigate the activity of taurine on apoptosis of mouse osteoblastic MC3T3-E1 cells. The data showed that 1, 5, 10, or 20 mM taurine resulted in 16.7, 34.2, 66.9, or 63.75 percent reduction of MC3T3-E1 cell apoptosis induced by the serum deprivation (serum-free α-MEM), respectively. Taurine (1, 5, or 10 mM) also reduced cytochrome c release and inhibited activation of caspase-3 and -9, which were measured using fluorogenic substrates for caspase-3/caspase-9, in serum-deprived MC3T3-E1 cells. Furthermore, taurine (10 mM) induced extracellular signal-regulated kinase (ERK) phosphorylation in MC3T3-E1 cells. Knockdown of the taurine transporter (TAUT) or treatment with the ERK-specific inhibitor PD98059 (10 μM) blocked the activation of ERK induced by taurine (10 mM) and abolished the anti-apoptotic effect of taurine (10 mM) in MC3T3-E1 cells. The present results demonstrate for the first time that taurine inhibits serum deprivation-induced osteoblast apoptosis via the TAUT/ERK signaling pathway.


Assuntos
Animais , Bovinos , Camundongos , Apoptose/efeitos dos fármacos , Apoptose/fisiologia , MAP Quinases Reguladas por Sinal Extracelular/metabolismo , Glicoproteínas de Membrana/metabolismo , Proteínas de Membrana Transportadoras/metabolismo , Osteoblastos/efeitos dos fármacos , Taurina/farmacologia , Análise de Variância , Caspase 9/metabolismo , /metabolismo , Osteoblastos/metabolismo , RNA Mensageiro/metabolismo
17.
Arq. neuropsiquiatr ; 69(2b): 360-364, 2011. ilus, tab
Artigo em Inglês | LILACS | ID: lil-588098

RESUMO

Pilocarpine-induced seizures can be mediated by increases in oxidative stress and by cerebral amino acid changes. The present research suggests that antioxidant compounds may afford some level of neuroprotection against the neurotoxicity of seizures in cellular level. The objective of the present study was to evaluate the lipoic acid (LA) effects in glutamate and taurine contents in rat hippocampus after pilocarpine-induced seizures. Wistar rats were treated intraperitoneally (i.p.) with 0.9 percent saline (Control), pilocarpine (400 mg/kg, Pilocarpine), LA (10 mg/kg, LA), and the association of LA (10 mg/kg) plus pilocarpine (400 mg/kg), that was injected 30 min before of administration of LA (LA plus pilocarpine). Animals were observed during 24 h. The amino acid concentrations were measured using high-performance liquid chromatograph (HPLC). In pilocarpine group, it was observed a significant increase in glutamate content (37 percent) and a decrease in taurine level (18 percent) in rat hippocampus, when compared to control group. Antioxidant pretreatment significantly reduced the glutamate level (28 percent) and augmented taurine content (32 percent) in rat hippocampus, when compared to pilocarpine group. Our findings strongly support amino acid changes in hippocampus during seizures induced by pilocarpine, and suggest that glutamate-induced brain damage plays a crucial role in pathogenic consequences of seizures, and imply that strong protective effect could be achieved using lipoic acid through the release or decrease in metabolization rate of taurine amino acid during seizures.


As convulsões induzidas pela pilocarpina podem ser mediadas através do aumento do estresse oxidativo cerebral e das alterações na concentração dos aminoácidos. O presente estudo sugere que compostos antioxidantes podem produzir neuroproteção contra a neurotoxicidade em nível celular causada pelas convulsões. O objetivo deste estudo foi avaliar os efeitos do ácido lipóico (AL) no conteúdo de glutamato e taurina no hipocampo de ratos durante convulsões induzidas por pilocarpina. Ratos Wistar foram tratados por via intraperitoneal com solução salina 0,9 por cento (controle), pilocarpina (400 mg/kg, pilocarpina), AL (10 mg/kg) e com a associação de AL (10 mg/kg); 30 min após com pilocarpina (400 mg/kg), que foi injetada 30 min após a administração de AL (AL + pilocarpina). Os animais foram observados durante 24 horas. As concentrações de aminoácidos foram determinadas por HPLC. No hipocampo dos ratos do grupo pilocarpina foi observado um aumento significativo de 37 por cento na concentração de glutamato e uma diminuição de 18 por cento no nível de taurina, quando comparado ao grupo controle. O pré-tratamento com o antioxidante reduziu significativamente o nível de glutamato em 28 por cento e aumentou em 32 por cento os níveis de taurina no hipocampo dos ratos, quando comparado ao grupo pilocarpina. Nossos resultados sugerem que ocorrem alterações na concentração dos aminoácidos no hipocampo de ratos durante as convulsões induzidas por pilocarpina, e que o glutamato pode desempenhar um papel crucial na fisiopatologia das convulsões, e que o efeito protetor poderia ser alcançado com pré-tratamento com ácido lipóico, provavelmente pelo aumento da liberação ou redução da taxa de metabolização dos aminoácidos durante as convulsões.


Assuntos
Animais , Masculino , Ratos , Antioxidantes/farmacologia , Ácido Glutâmico/metabolismo , Hipocampo/efeitos dos fármacos , Convulsões/metabolismo , Taurina/metabolismo , Ácido Tióctico/farmacologia , Cromatografia Líquida de Alta Pressão , Hipocampo/química , Pilocarpina , Ratos Wistar , Convulsões/induzido quimicamente , Convulsões/tratamento farmacológico
19.
Rev. bras. med. esporte ; 15(2): 123-126, mar.-abr. 2009. graf, tab
Artigo em Português | LILACS | ID: lil-513164

RESUMO

Segundo a Secretaria de Vigilância Sanitária do Ministério da Saúde, bebidas energéticas são identificadas como compostos líquidos prontos para o consumo, sendo estas constituídas de carboidratos, taurina, cafeína, glucoronolactona, inositol e vitaminas do complexo B. Existem poucas pesquisas sobre o uso de taurina contida em bebidas energéticas relacionado com a melhora de desempenho. Este trabalho teve como objetivo analisar as respostas metabólicas e hemodinâmicas decorrentes da administração da associação de taurina e cafeína durante teste ergoespirométrico em indivíduos fisicamente ativos. Para esse fim, 20 indivíduos do sexo masculino, 26 ± 4,32 anos e índice de massa corporal 23,79 ± 2,95, praticantes de atividades aeróbicas, foram submetidos a duas sessões de testes em cicloergômetro ligado a analisador metabólico de gases. O esquema das sessões foi duplo- cego e 60 minutos antes do início dos testes foi oferecida bebida experimental ou bebida placebo. Durante os testes, foram mensuradas: frequência cardíaca (FC), pressão arterial sistólica (PAS) e diastólica (PAD), lactato sanguíneo (Lac), percepção subjetiva de esforço por escala de Borg (PSE), consumo máximo de oxigênio (VO2máx), consumo de oxigênio no ponto de compensação respiratório (RCP), tempo de exercício (TE) e carga de trabalho (CAR). Para a análise dos dados, foi realizado um teste t pareado (p ≤ 0,05). Na carga de trabalho, os resultados indicaram que houve aumento de 10 watts com a administração da bebida experimental, contudo, sem significância estatística (BE: 342 ± 40,60; P: 332,50 ± 56,83). Os principais resultados deste estudo indicam que a administração de taurina contida em bebida energética não influenciou os resultados das variáveis investigadas. Assim, podemos concluir que a dose de 2g utilizada não foi capaz de aumentar o desempenho.


According to the Sanitary Surveillance Agency of the Ministry of Health, energy drinks are identified as liquid compounds ready for consumption, being made of carbohydrates, taurine, caffeine, glucoronolactone, inositol, and B-complex vitamins. Given the small number of studies on the use of taurine in energy drinks related to improved performance, this paper aimed to analyze the metabolic and haemodynamic responses resulted from the administration of the association of taurine and caffeine during an ergospyrometric test in physically active subjects. Therefore, twenty male individuals, 26 ±4.32 years and body mass 23.79 ±2.95, frequent practitioners of aerobic activities, were submitted to two test sessions in cycle ergometer hooked to a gas metabolic analyzer. The sessions schedule was double-blind, and 60 minutes before them the individuals were offered experimental drinks or placebo drinks. During the tests, the subjects were evaluated on the following variables: heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP), blood lactate (Lac), subjective perceived exertion by Borg scale (SPE), maximum oxygen uptake (VO2max), oxygen uptake at the compensation respiratory point (CRP), exercise time (ET) and work load (WL). A paired t test was carried out for data analysis, where (p≤0.05). On the work load, the results indicated an increase of 10 watts with the administration of the experimental drink, with no statistical significance, though. (ED: 342 ±40.60; P: 332.50±56.83). The main results of this study point out that taurine administration contained in the energy drink did not influence in the levels of the investigated variables. Thus, we can conclude that the 2g dose used did not improve performance.


Assuntos
Humanos , Masculino , Adulto Jovem , Cafeína/metabolismo , Suplementos Nutricionais , Alimentos para Praticantes de Atividade Física , Diálise Renal , Taurina/metabolismo
20.
Nutrire Rev. Soc. Bras. Aliment. Nutr ; 34(1): 211-223, abr. 2009. ilus
Artigo em Português | LILACS | ID: lil-517525

RESUMO

Alteration of ventricular weight, structure, geometry and volume in response to alteration of loading conditions or myocardial injury are viewed as examples of ventricular remodeling. It is well accepted that ventricular remodeling is initially a compensatory process infl uenced by hemodynamic overload or neurohormonal activation. However, chronic ventricular remodeling is now recognized as a pathological process, which results in progressive ventricular dysfunction and clinical presentation of heart failure or sudden death. Several experimental and clinical studies showedthat reduced taurine levels are associated with important cardiovascular alterations. Likewise, taurine supplementation attenuated the cardiac remodeling induced by different injuries. Some theories have been proposed to account for the cardioprotective activity of taurine: role similar to diuretics, since it promotes sodium and water excretion; modulating role on several relevant ions for the normal functioning of the cardiac cell;protection of the liposomal membranes against damages caused by freeradicals and antagonic action to angiotensin II reduction of the salt andfluid load; sodium and calcium modulation; protection against oxidativestress; and attenuation of the angiotensin II actions on ion transport, protein synthesis and angiotensin signaling. Therefore, the evidences suggest that taurine might play a critical role in the cardiac remodeling process.


La remodelación cardíaca es defi nida como variaciones moleculares e intersticiales que se manifiestan clínicamente por medio dealteraciones en el tamaño, masa, geometría y función del corazón en respuesta a determinada agresión. La remodelación ventricular tienecomo objetivo principal mantener la función cardíaca estable en situaciones de agresión. Sin embargo, crónicamente, con la continuidado progreso del proceso ocurre disfunciónventricular progresiva y muerte. Diversos estudios experimentales y clínicos han sugerido que la reducción de las concentraciones de taurina resulta en importantes modifi cacionescardiovasculares. Otra línea de evidencia sugestiva de la relevancia de la taurina para el corazón es que su suplementación ha atenuado el proceso de remodelación en diferentes situaciones de agresión. En relacióncon los mecanismos propuestos para explicar los efectos benéfi cos de la taurina en el proceso de remodelación cardíaca, se destacan: el papel semejante a los diuréticos por promoverexcreción de sodio y agua; el papel modulador de diversos iones relevantes para el funcionamiento normal de la célula cardíaca; la protecciónde las membranas liposómicas contra daños causados por radicales libres y, fi nalmente, la acción antagonista de angiotensina II. Así, las evidencias hasta el momento permitensuponer que la taurina puede desempeñar un papel crítico en la modulación del proceso deremodelación cardíaca.


A remodelação cardíaca é definida comovariações moleculares e intersticiais, que se manifestam clinicamente por meio de alterações no tamanho, massa, geometria e na função docoração em resposta à determinada agressão. A princípio, a remodelação ventricular tem como objetivo manter a função cardíaca estável em situações de agressão. Cronicamente, entretanto, com a continuidade e/ou progressão do processo ocorre disfunção ventricular progressiva e morte. Diversos estudos experimentais e clínicos têm sugerido que a redução das concentraçõesde taurina resulta em importantes modificações cardiovasculares. Do mesmo modo, outra linhade evidência sugestiva da relevância da taurina para o coração é que sua suplementação atenuou o processo de remodelação em diferentes situações de agressão. Em relação aos mecanismos propostos para explicar os efeitosbenéficos da taurina no processo de remodelação cardíaca, destacam-se: papel semelhante aos diuréticos, por promover a excreção de sódioe água; papel modulador de diversos íons relevantes para o funcionamento normal da célula cardíaca; proteção das membranas lipossômicas contra danos causados por radicais livres e, fi nalmente, ação antagonista da angiotensina II. Assim, as evidências até o momento permitem a suposição de que a taurina pode desempenhar papel crítico na modulação do processo da remodelação cardíaca.


Assuntos
Aditivos Alimentares/uso terapêutico , Remodelação Ventricular/fisiologia , Taurina/biossíntese , Suplementos Nutricionais
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...